Literature DB >> 16307482

B-Raf and C-Raf signaling investigated in a simplified model of the mitogenic kinase cascade.

Armin Robubi1, Tobias Mueller, Jochen Fueller, Mirko Hekman, Ulf R Rapp, Thomas Dandekar.   

Abstract

Signaling pathways based on the reversible phosphorylation of proteins control most aspects of cellular life in higher organisms. Extracellular stimuli can induce growth, differentiation, survival and the stress response through a number of highly conserved signaling pathways. We discuss how the intensity and duration of signals may have dramatic consequences on the way cells respond to stimuli. Picking the central Ras-Raf-MEK-ERK signal cascade, we developed a mathematical model of how stimuli induce different signal patterns and thereby different cellular responses, depending on cell type and the ratio between B-Raf and C-Raf. Based on biochemical data for activation and dephosphorylation, as well as the differential equations of our model, we suggest a different signaling pattern and response result for B-Raf (strong activation, sustained signal) and C-Raf (steep activation, transient signal). We further support the significance of such differential modulatory signaling by showing different Raf isoform expression in various cell lines and experimental testing of the predicted kinase activities in B-Raf, C-Raf and mutated versions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307482     DOI: 10.1515/BC.2005.133

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  2 in total

1.  A combined tissue-engineered/in silico signature tool patient stratification in lung cancer.

Authors:  Claudia Göttlich; Meik Kunz; Cornelia Zapp; Sarah L Nietzer; Heike Walles; Thomas Dandekar; Gudrun Dandekar
Journal:  Mol Oncol       Date:  2018-06-22       Impact factor: 6.603

2.  How to Steer and Control ERK and the ERK Signaling Cascade Exemplified by Looking at Cardiac Insufficiency.

Authors:  Tim Breitenbach; Kristina Lorenz; Thomas Dandekar
Journal:  Int J Mol Sci       Date:  2019-05-02       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.